News Sentiment

HEMO sentiment intelligence

Hemogenyx Pharmaceuticals Plc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 51 Balanced news tone 11 relevant articles
Exchange LSE United Kingdom
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 7.75 Week of 10 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

85/100 classification confidence.

Company focus 11

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+0.6% over one week, -6.1% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Price to earnings forward of HemoGenyx Pharmaceuticals Plc – LSE:HEMO

Market Reaction

Balanced read

51/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 85/100 classification
One-week reaction 0.6% Price digesting
Trend fit Trend inactive -6.1% over four weeks
Fair value -98.7% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 1
Neutral 10
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 11
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 3
TradingView 2
Kalkine Media 2
Market source 1
simplywall.st 1
intelligentinvestor.com.au 1
Investing.com UK 1

Event Lens

What the news is about

Classified themes
Market update 8
Earnings 3

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-11 of 11